V. Tjan-Heijnen

发表

Relevant impact of central pathology review on nodal classification in individual breast cancer patients.

P. V. van Diest, P. Bult, C. Seynaeve, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients

V. Tjan-Heijnen, V. Tjan-Heijnen, M. Lobbes, 2014, Breast Cancer Research and Treatment.

Population‐based study of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ

L. Kooreman, V. Tjan-Heijnen, V. Tjan-Heijnen, 2019, The British journal of surgery.

Abstract S1-03: First results from the multicenter phase III DATA study comparing 3 versus 6 years of anastrozole after 2-3 years of tamoxifen in postmenopausal women with hormone receptor-positive early breast cancer

C. Seynaeve, S. Linn, V. Tjan-Heijnen, 2017 .

Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.

V. Tjan-Heijnen, V. Tjan-Heijnen, R. Roumen, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.

V. Tjan-Heijnen, V. Tjan-Heijnen, R. Roumen, 2016, Breast.

Inconsistent selection and definition of local and regional endpoints in breast cancer research

V. Tjan-Heijnen, L. Strobbe, V. Tjan-Heijnen, 2014, The British journal of surgery.

Abstract OT2-1-03: The Z11 design for breast cancer patients undergoing a mastectomy

S. Linn, V. Tjan-Heijnen, J. Hage, 2012 .

Breast cancer patient-reported outcome of factors influencing cosmetic satisfaction after breast-conserving therapy

V. Tjan-Heijnen, L. V. van Osch, A. Maaskant-Braat, 2021, Breast Cancer.

Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.

P. Neven, R. Steele, A. Vincent-Salomon, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.

V. Tjan-Heijnen, L. V. van de Poll-Franse, M. Ernst, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Trends in delayed breast cancer diagnosis after recall at screening mammography.

V. Tjan-Heijnen, R. Pijnappel, L. Strobbe, 2021, European journal of radiology.

Presence of symptoms and timing of surgery do not affect the prognosis of patients with primary metastatic breast cancer.

V. Tjan-Heijnen, G. Nieuwenhuijzen, M. Ernst, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease.

V. Tjan-Heijnen, M. Koolen, R. Kurstjens, 1994, The Netherlands journal of medicine.

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium.

M. de Boer, V. Tjan-Heijnen, N. Peters, 2017, European journal of cancer.

Abstract GS1-07: The genomic landscape of 501 metastatic breast cancer patients

S. Sleijfer, J. Martens, M. Smid, 2019, General Session Abstracts.

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

P. Neven, V. Tjan-Heijnen, I. Láng, 2020, Clinical and Translational Oncology.

The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry

M. Pepels, M. de Boer, V. Tjan-Heijnen, 2020, Acta oncologica.

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)

L. Boersma, S. Linn, K. K. van de Vijver, 2015, BMC Cancer.

Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer.

J. Bussink, C. Punt, J. Beijnen, 2008, Lung cancer.

Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.

F. Hoebers, V. Tjan-Heijnen, G. Nieuwenhuijzen, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer

M. de Boer, V. Tjan-Heijnen, D. V. van Spronsen, 2017, Breast Cancer Research and Treatment.

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer.

M. de Boer, G. Borm, V. Tjan-Heijnen, 2013, European journal of cancer.

Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer

V. Tjan-Heijnen, J. Roukema, A. Voogd, 2012, Indian Journal of Surgical Oncology.

Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer

V. Tjan-Heijnen, G. Nieuwenhuijzen, J. Roukema, 2011, Annals of Surgical Oncology.

Reliability of receptor assessment on core needle biopsy in breast cancer patients

V. Tjan-Heijnen, V. Tjan-Heijnen, M. Nap, 2013, Tumor Biology.

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

L. Boersma, S. Linn, K. K. van de Vijver, 2017, BMC Cancer.

Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.

V. Tjan-Heijnen, V. Tjan-Heijnen, G. Nieuwenhuijzen, 2013, European journal of cancer.

5005 Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis

V. Tjan-Heijnen, M. Ernst, A. Voogd, 2009 .

Abstract P1-13-06: Does histological subtype play a role in treatment decision-making for hormone receptor positive metastatic breast cancer? A study of the Southeast Netherlands breast cancer consortium

V. Tjan-Heijnen, R. Roumen, T. Smilde, 2016 .

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer

V. Tjan-Heijnen, V. Tjan-Heijnen, G. Nieuwenhuijzen, 2015, Annals of Surgical Oncology.

Abstract OT2-07-08: Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

A. Jager, S. Linn, V. Tjan-Heijnen, 2018 .

Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancer.

P. Bult, T. Wobbes, E. Adang, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands.

J. Coebergh, V. Tjan-Heijnen, M. Janssen-Heijnen, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Is the sentinel lymph node pathology protocol in breast cancer patients associated with the risk of regional recurrence?

P. Bult, T. Wobbes, M. Pepels, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands

V. Tjan-Heijnen, E. Bastiaannet, M. Ernst, 2011, Breast Cancer Research and Treatment.

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

J. Wildberger, V. Tjan-Heijnen, R. Beets-Tan, 2013, Insights into Imaging.

Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review

J. Wildberger, V. Tjan-Heijnen, R. Beets-Tan, 2012, European Radiology.

Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.

V. Tjan-Heijnen, P. Poortmans, A. Voogd, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Treatment and survival of patients with non-small cell lung cancer Stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands.

A. Verbeek, J. V. van Dijck, V. Tjan-Heijnen, 2001, Lung cancer.

V. Tjan-Heijnen, A. Maaskant-Braat, A. Brands-Appeldoorn, 2021, Breast Cancer Research and Treatment.

Patients with Invasive Lobular Breast Cancer Are Less Likely to Undergo Breast-Conserving Surgery: A Population Based Study in The Netherlands

V. Tjan-Heijnen, S. Siesling, R. Roumen, 2014, Annals of Surgical Oncology.

Abstract PD6-03: Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

V. Tjan-Heijnen, J. Derhaag, C. Die-Smulders, 2017 .

Micrometastases and isolated tumor cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists' group (BOOG)

P. Bult, C. Seynaeve, E. Rutgers, 2009 .

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

J. Nortier, V. Tjan-Heijnen, E. Voest, 2011, Breast Cancer Research and Treatment.

Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis

V. Tjan-Heijnen, S. Siesling, R. Roumen, 2017, Breast Cancer Research and Treatment.

Impact of Hospital Volume on Breast Cancer Outcome: A Population Based Study in the Netherlands.

V. Tjan-Heijnen, S. Siesling, O. Visser, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Contrast enhanced mammography: techniques, current results, and potential indications.

J. Wildberger, V. Tjan-Heijnen, V. Tjan-Heijnen, 2013, Clinical radiology.

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy

J. Foekens, C. Sweep, V. Tjan-Heijnen, 2002, British Journal of Cancer.

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?

M. de Boer, V. Tjan-Heijnen, V. Tjan-Heijnen, 2015, British Journal of Cancer.

Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0[i+]) in the sentinel lymph node (SN): Results from the MIRROR study.

P. V. van Diest, P. Bult, M. Pepels, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

G. Giaccone, E. Smit, M. Krzakowski, 2003, European Journal of Cancer.

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

J. A. van der Hage, S. Linn, V. Tjan-Heijnen, 2017, BMC Cancer.

Multi-center validation of the 76-gene prognostic signature in lymph node negative (LNN) primary breast cancer

David C. Atkins, J. Foekens, C. Sweep, 2005 .

Models predicting non-sentinel node involvement also predict for regional recurrence in breast cancer patients without axillary treatment.

P. V. van Diest, P. Bult, J. Vestjens, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.